Price $193.51 |
Market Cap
3.41B
|
Sector All |
Div. Growth
37.90%
|
|
P/E
38.4
|
P/B
4.26
|
P/S
2.94
|
Dividend %
1.10%
|
|
P/CF
57.0
|
P/FCF
76.9
|
Op. Cash Flow
139.2K
|
FCF
2.3
|
|
Op. Margin
10.00%
|
Net Margin
7.80%
|
ROE
11.80%
|
ROI
8.90%
|
|
ROA
9.70%
|
EPS Growth
-12.50%
|
Current Ratio
3.2
|
Debt/Equity
0.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Dougherty's Pharmacy Inc (MYDP) | $0.06 | - | - | 2.1M | Strong Buy |
| MusclePharm Corp (MSLP) | $0.41 | - | - | 7.7M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $2.04 | - | - | 23.4M | Strong Buy |
| PURE Bioscience (PURE) | $0.31 | - | - | 24.1M | Strong Buy |
| BIQI International Holdings Co (BIQI) | $0.69 | - | - | 6.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
